Andriy Durygin

Dr. Andriy Durygin

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Tribology International
Verified
Journal Article
Closed access
DLDebrupa Lahiri
Debrupa Lahiri
FHFrancois Hec
Francois Hec
MTMikael Thiesse
Mikael Thiesse
ADAndriy Durygin
Andriy Durygin
CZCheng Zhang
Cheng Zhang
AAArvind Agarwal
Arvind Agarwal

25 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
URUpal Roy
Upal Roy
VDVadym Drozd
Vadym Drozd
ADAndriy Durygin
Andriy Durygin
JRJesse Rodriguez
Jesse Rodriguez
PBPaul Barber
Paul Barber
MNMadhavan Nair
Madhavan Nair
Human Immunodeficiency Virus Type 1 (HIV-1) remains one of the leading causes of death worldwide. Present combination antiretroviral therapy has substantially improved HIV-1 related pathology. However, delivery of therapeutic agents to the HIV reservoir organ like Central nervous system (CNS) remains a major challenge primarily due to the ineffective transmigration of drugs through Blood Brain Barrier (BBB). The recent advent of nanomedicine-based drug delivery has stimulated the development of innovative systems for drug delivery. In this regard, particular focus has been given to nanodiamond due to its natural biocompatibility and non-toxic nature–making it a more efficient drug carrier than other carbon-based materials. Considering its potential and importance, we have characterized unmodified and surface-modified (-COOH and -NH2) nanodiamond for its capacity to load the anti-HIV-1 drug efavirenz and cytotoxicity,in vitro. Overall, our study has established that unmodified nanodiamond conjugated drug formulation has significantly higher drug loading capacity than surface-modified nanodiamond with minimum toxicity. Further, this nanodrug formulation was characterized by its drug dissolution profile, transmigration through the BBB, and its therapeutic efficacy. The present biological characterizations provide a foundation for further study ofin-vivopharmacokinetics and pharmacodynamics of nanodiamond-based anti-HIV drugs.

23 November 2006 in Journal of Physics: Condensed Matter
Verified
Journal Article
Closed access
YZYa Zhydachevskii
Ya Zhydachevskii
DGD Galanciak
D Galanciak
SKS Kobyakov
S Kobyakov
MBM Berkowski
M Berkowski
Agata KaminskaAgata Kaminska
Agata Kaminska
ADAndriy Durygin
Andriy Durygin

1 January 2005 in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
Verified
Journal Article
Closed access
YZYa. Zhydachevskii
Ya. Zhydachevskii
ADAndriy Durygin
Andriy Durygin
ASAndrzej Suchocki
Andrzej Suchocki
AMA. Matkovskii
A. Matkovskii
DSD. Sugak
D. Sugak
SWS. Warchol
S. Warchol

1 October 2004 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
TAT. Aitasalo
T. Aitasalo
ADAndriy Durygin
Andriy Durygin
JHJ. Hölsä
J. Hölsä
MLM. Lastusaari
M. Lastusaari
JNJ. Niittykoski
J. Niittykoski
ASAndrzej Suchocki
Andrzej Suchocki

1 May 2019 in Journal of Materials Research and Technology
Verified
Journal Article
Open access
EMEduin Yesid Mora Mendoza
Eduin Yesid Mora Mendoza
ASArmando Sarmiento Santos
Armando Sarmiento Santos
ELEnrique Vera López
Enrique Vera López
VDVadym Drozd
Vadym Drozd
ADAndriy Durygin
Andriy Durygin
SSSurendra K Saxena
Surendra K Saxena